Guided Therapeutics (GTHP) Minority Interest (2010 - 2012)

Guided Therapeutics recorded quarterly Minority Interest of $104000.0 in Q3 2012, little changed quarter-over-quarter from $104000.0 in Q2 2012.

Guided Therapeutics' Minority Interest history runs 3 years deep, the most recent figure standing at $104000.0 for Q3 2012.

  • In Q3 2012, Minority Interest changed N/A year-over-year to $104000.0; the TTM figure through Sep 2012 stood at $104000.0 (changed N/A YoY), while the FY2011 annual figure was $104000.0, changed 0.0% from the prior year.
  • Minority Interest came in at $104000.0 for Q3 2012 at Guided Therapeutics, roughly flat from $104000.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $104000.0 in Q4 2010 to a low of $104000.0 in Q4 2010.
  • A 3-year average of $104000.0 and a median of $104000.0 in 2010 frame the typical range for Minority Interest.
  • On a YoY basis, Minority Interest climbed as much as 0.0% in 2011 and fell as far as 0.0% in 2011.
  • Guided Therapeutics' Minority Interest stood at $104000.0 in 2010, then changed by 0.0% to $104000.0 in 2011, then changed by 0.0% to $104000.0 in 2012.
  • According to Business Quant data, Minority Interest over the past three periods registered $104000.0, $104000.0, and $104000.0 for Q3 2012, Q2 2012, and Q1 2012 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Guided Therapeutics - - 458,000.00

Historic Data

Download Data 🔒
DateValue
Sep 30, 2012 104,000.00
Jun 30, 2012 104,000.00
Mar 31, 2012 104,000.00
Dec 31, 2011 104,000.00
Dec 31, 2010 104,000.00